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Abstract
 
NG2-glia are a substantial population of cells in the central nervous system (CNS) that can be identified by their
specific expression of the NG2 chondroitin sulphate (CSPG). NG2-glia can generate oligodendrocytes, but it is
unlikely this is their only function; indeed, they may be multipotent neural stem cells. Moreover, NG2-glia are a
highly reactive cell type and a major function is to help form the axon growth inhibitory glial scar in response to
CNS injury. The factors that regulate these diverse behaviours of NG2-glia are not fully resolved, but NG2-glia express
receptors to the neurotransmitter glutamate, which has known potent effects on other glia. Here, we have exam-
ined the actions of glutamate receptor activation on NG2-glia in the rat optic nerve, a typical CNS white matter
tract that does not contain neuronal cell bodies. Glutamate induces an increase in [Ca
 
2+
 
]
 
i
 
 in immuno-identified
NG2-glia 
 
in situ
 
 and 
 
in vitro
 
. In addition, we examined the effects of glutamate receptor activation 
 
in vivo
 
 by focal
injection of the glutamate receptor agonist kainate into the optic nerve; saline was injected in controls. Changes
in glial and axonal function were determined at 7 days post injection (dpi), by immunohistochemistry and electro-
physiological measurement of the compound action potential (CAP). Injection of kainate resulted in a highly localized
‘injury response’ in NG2-glia, marked by dense labelling for NG2 at the lesion site, as compared to astrocytes, which
displayed a more extensive reactive astrogliosis. Furthermore, injection of kainate resulted in an axonal conduction
block. These glial and axonal changes were not observed following injection of saline vehicle. In addition, we provide
evidence that endogenous glutamate induces calcium-dependent phosphorylation of extracellular signal-regulated
kinases (ERK1/2), which may provide a potential mechanism by which glutamate-mediated changes in raised intra-
cellular calcium could regulate the observed gliosis. The results provide evidence that activation of AMPA-kainate type
ionotropic glutamate receptors evoke raised calcium in NG2-glia and induces an injury response in NG2-glia.
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Introduction
 
The NG2 chondroitin sulphate proteoglycan (CSPG) identifies
a major population of glial cells in the adult central nervous
system (Levine & Card, 1987; Levine & Stallcup, 1987; Stallcup
& Beasley, 1987; Nishiyama et al. 1996a,b). These ‘NG2-glia’
are distinct from the other glial cell types, namely astrocytes,
oligodendrocytes, microglia and ependymal cells, but
NG2-glia do express markers of oligodendrocyte progenitor
cells (OPCs), such as platelet-derived growth factor alpha
receptors (PDGF
 
α
 
R) and Nkx2.2 (Nishiyama et al. 1996a,b;
Watanabe et al. 2004). NG2-glia can generate both
oligodendrocytes and astrocytes (Zhu et al. 2008), and so may
be the 
 
in vivo
 
 equivalent of oligodendrocyte-type-2
astrocyte (O-2A) cells isolated from neonatal and adult
CNS by Raff and colleagues (Raff et al. 1983; ffrench-
Constant et al. 1986). NG2-glia may also be programmed
to act as multipotent neural stem cells that can also gen-
erate neurons (Kondo & Raff, 2000; Belachew et al. 2003;
Aguirre et al. 2004). Many studies refer to NG2-glia as
OPCs, but we have also termed them synantocytes to
reflect their non-OPC nature in the adult CNS (Butt et al.
2002). The distinguishing feature of these cells is their
expression of the NG2 CSPG and so in this paper we will
refer to them simply as NG2-glia. The majority of NG2-glia
retain an OPC phenotype in the adult CNS, and can
regenerate oligodendrocytes following demyelination in
multiple sclerosis (MS) in humans and in animal models of
MS (Polito & Reynolds, 2005). In addition, NG2-glia are a
highly reactive cell type that respond to most CNS insults
by a rapid gliosis, comprising cell proliferation and up-
regulation of the NG2 CSPG (Levine, 1994). Indeed, NG2-glia
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are an important element of the neuroprotective glial
scar and the NG2 CSPG is a major inhibitor of axon
regeneration in the CNS (Sandvig et al. 2004; Tan et al.
2005, 2006).
The factors that regulate the diverse responses of
NG2-glia to demyelination and injury are unresolved,
but several lines of evidence indicate a potential role for
the neurotransmitter glutamate (Butt, 2006). Firstly,
NG2-glia express AMPA-type glutamate receptors that
are activated by glutamate released at synapses in grey
matter (Bergles et al. 2000; Lin et al. 2005) and by axons in
white matter (Kukley et al. 2007; Ziskin et al. 2007). In
addition, there is evidence that AMPA receptors on NG2-
glia are permeable to Ca
 
2+
 
 (Fulton et al. 1992; Butt et al.
2005; Ziskin et al. 2007), and this would provide a mecha-
nism by which glutamate could regulate intracellular
pathways that control cell proliferation, growth, differentiation
and death, such as the calcium-dependent mitogen-
associated phosphate kinases (MAPK), extracellular signal-
regulated kinases (ERK1/2). Finally, glutamate has a
well-defined role in the pathology of oligodendrocyte
lineage cells (Alberdi et al. 2005). For example, OPCs and
oligodendrocytes are extremely susceptible to glutamate-
mediated calcium-dependent excitotoxicity (Liu et al.
2002; Matute et al. 2006), and injection of the potent
glutamate receptor agonist kainate into the white matter
of the optic nerve has been shown to cause demyelination
and the loss of oligodendrocytes (Matute et al. 1997, Matute,
1998). Moreover, injection of kainate into the cerebral
cortex induced an extensive gliosis in NG2-glia (Ong &
Levine, 1999). We therefore examined the potential role
for glutamate in driving calcium-dependent processes that
may regulate the responses of NG2-glia to CNS insults.
Some preliminary data have been presented in review
articles (Butt et al. 2005; Butt, 2006; Wigley et al. 2007).
In this paper, we provide evidence that glutamate evokes
raised [Ca
 
2+
 
]
 
i
 
 in NG2-glia and that injection of kainate into
the optic nerve induces an injury response in NG2-glia,
in apparent contradiction to the excitotoxic actions of
glutamate in OPCs. In addition, we provide evidence that
endogenous glutamate induces raised pERK1/2 (calcium-
dependent MAPK) in isolated optic nerves. The results
support a role for glutamate signalling in the injury response
of NG2-glia.
 
Materials and methods
 
Animals
 
Wistar rats (Charles River, UK) of either sex were used. Rats were
killed humanely by lethal injection of sodium pentobarbitone
(i.p.) and optic nerves removed for calcium imaging, cell culture,
Western blot, electrophysiology or immunohistochemistry. All
procedures were performed in accordance with regulations issued
by the Home Office of the United Kingdom under the Animals
(Scientific Procedures) Act, 1986.
 
Optic nerve explant cultures
 
The methods have been described in detail previously (Greenwood
& Butt, 2003). In brief, optic nerves from rat pups aged postnatal
day 6 (P6) were dissected free and cut into small pieces (~0.5 mm
 
3
 
).
Individual pieces were explanted onto a numbered micro-grid
coverslip glued to the bottom of Petri dishes and incubated in
DMEM (Dulbecco’s modified Eagle’s medium: 1% fetal calf serum,
0.1% gentamycin, 5.6 mg mL
 
−
 
1
 
 glucose, 0.5 
 
μ
 
g mL
 
−
 
1
 
 insulin, 100 
 
μ
 
g mL
 
−
 
1
 
transferrin, 90 
 
μ
 
g mL
 
−
 
1
 
 bovine serum albumin, 1.6 
 
μ
 
g mL
 
−
 
1
 
 putrescine,
60 ng mL
 
−
 
1
 
 progesterone, 5.2 ng mL
 
−
 
1
 
 selenium, 200 
 
μ
 
M
 
 glutamine,
50 n
 
M
 
 T3 and glutamine) at 37 
 
°
 
C for 15–22 days 
 
in vitro
 
 (DIV).
 
Calcium imaging
 
Fura-2 AM calcium imaging was performed in isolated intact optic
nerves and in cultures of optic nerve explants (see above). Rats
aged P15–20 were used for calcium imaging of immuno-identified
NG2-glia 
 
in situ
 
, but calcium imaging of unidentified glia was
performed in nerves aged from P10 to P30, and adenosine 5
 
′
 
-
triphosphate (ATP) and glutamate evoked raised glial [Ca
 
2+
 
]
 
i
 
 at all
ages. Isolated intact optic nerves or optic nerve explant cultures
were incubated in 4 
 
μ
 
M
 
 Fura-2 AM (Molecular Probes) for 1 h at room
temperature (RT), in oxygenated artificial cerebrospinal fluid (aCSF,
m
 
M
 
: NaCl,133; KCl, 3; CaCl
 
2
 
, 1.5; NaH
 
2
 
PO
 
4
 
, 1.2; MgCl
 
2
 
, 1.0; 
 
D
 
-glucose.
10; HEPES, 10; pH 7.3). Dye-loaded optic nerves were placed on a
numbered micro-grid, like those on which optic nerve explants
were cultured, and in both cases this allowed recordings from
NG2-glia to be identified 
 
post hoc
 
 at the end of the experiments
using immunohistochemistry (see below). In addition, we performed
live cell immunolabelling, in which nerves (
 
n
 
 = 5) were incubated
in a cocktail of primary NG2 antibody and secondary rabbit IgG
antibody (see below), together with Fura-2 for 1 h prior to washes
in CSF and calcium imaging. In these cases, the cell somata of
NG2-positive cells were identified and cell bodies within a single
plane of focus were selected as regions of interest (ROI); several
ROI were simultaneously recorded in each experiment, and both
NG2-positive and NG2-negative cells in the same field and focal
plane were analysed. Calcium imaging was performed on an Olympus
upright microscope (BX50W1) using an Achroplan 
 
×
 
20 water
immersion lens and an optional 
 
×
 
2 multiplier, and tissues were
perfused continuously with oxygenated aCSF. Fura-2 was excited
alternately at 340 and 380 nm, using a Cairn monochromator
(Cairn Research Ltd, UK). Emissions were detected at 510 nm using
an intensified CCD camera or a Photometrics S-Coolsnap CCD camera
(both supplied by Cairn Research Ltd., UK). The monochromator
and the CCD camera were controlled and synchronized by A
 
XON
 
I
 
MAGING
 
 W
 
ORKBENCH
 
 5.1 (Axon Instruments), and quantitative measure-
ments were made using the same program. Signals were sampled
at 2 Hz and the change in the F340:F380 ratio relative to the
baseline fluorescence was recorded within a single plane of focus.
Multiple ROI in a single plane were simultaneously recorded in
each experiment, and at the end of the experiment, NG2 immuno-
labelling was performed (see below) and the co-ordinates of
NG2-glia on the micro-grids were revealed and related to the
recordings of the F340:F380 ratio, enabling the calcium responses
of identified NG2-glia to be analysed.
 
Application of test agents and data analysis
 
Unless otherwise stated, for calcium imaging experiments, agonists
were applied by bath application over the nerve for 30 s, and a
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recovery period of 10 min in aCSF was allowed after each agent.
Chemicals were dissolved directly in aCSF, and used at 100 
 
μ
 
M
 
unless otherwise stated. The following were used (from Tocris
Bioscience, Bristol, UK; or Sigma-Aldrich, Dorset, UK): ATP, 
 
L
 
-glutamic
acid (glutamate/Glu), kainic acid (kainate), cyclothiazide (CTZ), 2,3-
dioxo-6-nitro-1,2,3,4-tetrahydrobenzol[f]quinoxaline-7-sulfonamide
disodium salt (NBQX), tetrodotoxin citrate (TTX). ZERO-Ca
 
2+
 
 was
prepared by the removal of Ca
 
2+
 
 and addition of EGTA (1 m
 
M
 
). 
To examine the response to ATP and glutamate, each agonist
was applied sequentially, and the responses in multiple ROI (cell
somata) to both agents were recorded. Measurements within a
single nerve were paired responses in each ROI, and results were
expressed as the maximum change in ratio, after background
subtraction (
 
Δ
 
F340:F380). The mean (± SEM, where 
 
n
 
 represents
the number of cells, from at least three replicates) maximum
 
Δ
 
F340:F380 was calculated for each agent in NG2-positive and
NG2-negative cells, and compared for significance using unpaired
t-tests. 
In the case of the CTZ and NBQX, the response to glutamate was
measured in multiple ROI, from unidentified cells. The nerve was
then incubated in CTZ-CSF for 3 min, and the response to glutamate
+ CTZ measured in the same cells, before return to CTZ-CSF. After
a 10-min recovery period, the response to glutamate + CTZ + NBQX
was measured in the same cells. In each case, the maximum
change in ratio, after background subtraction (
 
Δ
 
F340:F380), was
measured and then expressed as a per cent of the glutamate
response in the same cell. The experiment was replicated in three
nerves, and the data was then expressed as mean per cent gluta-
mate response (± SEM), where 
 
n
 
 represents the number of cells
(
 
n
 
 = 148), and tested for significance using Mann–Whitney tests.
 
Post hoc
 
 immunohistochemical identification of 
NG2-glia for calcium imaging
 
The same antibodies were used for live cell immunolabelling, and 
 
post
hoc
 
 immunolabelling of cells cultures and isolated nerves: rabbit
anti-NG2 (Chemicon), diluted 1:500, and Alexa 568-conjugated
secondary anti-rabbit IgG (Molecular Probes), diluted at 1:100.
For 
 
post hoc
 
 immunolabelling, optic nerve explant cultures and
intact nerves were immersion fixed in 4% paraformaldehyde
(PFA) in phosphate-buffered saline (PBS) at RT for 20–60 min.
Following washes in PBS, a blocking stage was performed by incuba-
tion at RT for 30–60 min with 1.5% normal goat serum (NGS) plus
1% BSA in PBS, prior to incubation in primary antibody (2 h at RT
or overnight at 4 
 
°
 
C), and then secondary antibody (2 h at RT).
Finally, tissues were washed, mounted in citifluor (Sigma-Aldrich
Co.) and imaged using the same Olympus upright microscope
described above. NG2-glia were identified and their co-ordinates
on the micro-grids were related to the recordings of the changes
in glial calcium.
 
In vivo
 
 injections into the optic nerve
 
Rats (200–250 g) were placed under deep anaesthesia by intra-
peritoneal injection of combined hypnorm/hypnovel (0.2133 mg kg
 
−
 
1
 
fentanyl citrate, 6.75 mg kg
 
−
 
1
 
 fluanisone, 3.375 mg kg
 
−
 
1
 
 midazolam).
To expose the intra-orbital portion of the optic nerve, an incision
was made in the skin above the eye and the musculature and
lachrymal glands in the superior aspect of the orbit were deflected.
A small window was cut in the dural sheath of the optic nerve and
the optic nerve superficially impaled with a micropipette, via which
1 
 
μ
 
L of solution was pressure injected into the nerve parenchyma.
The injectate was sterile saline vehicle, kainate (1 mg mL
 
−
 
1
 
) or
tetrodotoxin (TTX, 100 
 
μ
 
M
 
), and contained monastrol blue for sub-
sequent localization of the injection site. Following injection,
lachrymal glands and musculature were carefully replaced and the
wound was repaired. Rats were maintained at 37 
 
°
 
C until they had
recovered from anaesthesia and then returned to their cages.
After 7 days post injection (dpi), rats were killed humanely by lethal
sodium pentobarbitone overdose (Lethobarb, Fort Dodge Animal
Health, UK), and optic nerves removed for immunohistochemistry
or electrophysiology.
 
Immunohistochemistry following 
 
in vivo
 
 injections
 
Immediately following dissection, optic nerves were immersion
fixed in 4% PFA in PBS for 1 h at RT. Following washes in PBS,
nerves were cryoprotected in 30% sucrose overnight at 4 
 
°
 
C, and
then embedded in blocks of OCT (BDH Laboratory Supplies, UK)
before being frozen. Sections were cut at 25 
 
μ
 
m using a cryostat
and then washed in PBS prior to double immunofluorescence
labelling for NG2 and glial fibrillary acidic protein (GFAP). Sections
were incubated at RT for 30–60 min with 1.5% NGS plus 1% BSA
in PBS to reduce non-specific binding of antibodies. Sections were
incubated in rabbit anti-NG2 (diluted 1:500) overnight at 4 
 
°
 
C, and
then incubated for 2 h at RT in Alexa 568-conjugated secondary
anti-rabbit IgG (Molecular Probes), diluted at 1:100. For double
immunolabelling, intermediary fixation and blocking stages were
performed between NG2 and GFAP immunolabelling. Following
immunolabelling for NG2, sections were postfixed in 4% PFA for
20 min at RT, and the blocking stage in NGS was repeated prior to
incubation in rabbit anti-GFAP (diluted 1:250) overnight at 4 
 
°
 
C,
and then incubation in fluorescein-conjugated anti-rabbit IgG
(diluted at 1:100). Following washes in PBS, sections were mounted
in citifluor and examined on an Olympus Provis microscope. Negative
controls in which the primary antibodies were omitted showed no
signal, and there was no evidence of cross-reactivity when one or
other of the primary antibodies was removed. In addition, single
labelling for either antibody revealed an equivalent distribution
of NG2 and GFAP as observed in double labelling, further indication
that cross-reactivity between NG2 and GFAP immunolabelling was
effectively blocked by the intermediary fixation and blocking stages.
Double immunofluorescence images of the lesions (
 
n
 
 = 3) were
captured using a Zeiss axiocam digital camera, with settings
maintained constant for each slide. Fluorescence intensity (FI) was
measured using KS300 image analysis software (Imaging Associates,
UK), in five fields of view (FOV) in each section, at the injection site
(A, identified by monastral blue), the penumbra proximal (P1) and
distal (P2) to the lesion, and at 500 
 
μ
 
m distance from the lesion,
both proximally (D1) and distally (D2). For each FOV, the FI was ex-
pressed as a per cent of the FI in untreated optic nerve, and the mean
(± SEM) per cent normal expression for NG2 and GFAP was calculated.
 
Measurement of the compound action potential (CAP)
 
Optic nerves were removed intact and maintained immediately in
chilled oxygenated aCSF (Bolton & Butt, 2005). Nerves were then
removed to a brain slice chamber and continuously perfused with
oxygenated aCSF at room temperature. One end of the nerve was
placed in a suction electrode connected to a stimulator (S44
stimulator, Grass Instruments, USA). The other end of the nerve
placed in a suction electrode connected to a differential amplifier
(Duo 773 Electrometer, World Precision Instruments Inc., USA), which
enabled subtraction of the stimulus artefact from the signal. CAPs
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were acquired on a PC via CED1401 analogue-to-digital interface
(Cambridge Electronic Design, UK), and analysed using S
 
IGNAL
 
2
software (Cambridge Electronic Design, UK). The peak CAP
amplitude was measured for each nerve, and the mean + SE calcu-
lated for each treatment group and tested for significance using
Mann–Whitney tests.
 
Incubation of optic nerves and Western blot analysis
 
Optic nerves from P10 rats were isolated intact and placed imme-
diately into ice-cold aCSF for 5–10 min prior to the start of the
experiment. Nerves were then incubated at 37 
 
°
 
C in either (1)
aCSF (untreated controls), (2) ZERO-Ca
 
2+
 
 CSF, (3) NBQX (dissolved
in CSF), or (4) kainate (dissolved in CSF). Five nerves were used in
each case to provide sufficient protein for Western blot analysis,
and each treatment was replicated at least three times (aCSF,
 
n
 
 = 7; ZERO-Ca
 
2+
 
 CSF, 
 
n
 
 = 3; NBQX CSF, 
 
n
 
 = 3; kainate CSF, 
 
n
 
 = 7).
At the end of 15 min incubation, nerves were washed in ice cold
Ca
 
2+
 
-free PBS containing 200 
 
μ
 
M
 
 EGTA and 200 
 
μ
 
M
 
 EDTA pH 7.4 and
placed immediately on ice to stop any further phosphorylation of
ERK. For Western blot analysis, nerves were then homogenized in
extraction buffer on ice for 45 min (50 m
 
M
 
 Tris, 150 m
 
M
 
 NaCl, 1%
Triton-X100, 2 m
 
M
 
 EDTA, 2 m
 
M
 
 EGTA, 0.5 m
 
M
 
 phenylmethylsulfo-
nylfluoride, 10 
 
μ
 
g mL
 
−
 
1
 
 leupeptin, 10 
 
μ
 
g mL
 
−
 
1
 
 antipain, 1 
 
μ
 
g mL
 
−
 
1
 
chymostatin, 1 
 
μ
 
g mL
 
−
 
1
 
 pepstatin A, 1 m
 
M
 
 sodium orthovanadate
and 50 m
 
M
 
 Naf, corrected to pH7.4 with HCl). Samples were
centrifuged at 5 
 
°
 
C for 5 min at 1000 
 
g
 
 and the supernatant
sampled for Bradford protein assay determination. Remaining
samples were immediately frozen at 
 
−
 
20 
 
°
 
C until required. For pro-
tein analysis, samples were then solubilized and denatured in SDS
boiling buffer (62.5 m
 
M
 
 Tris, 2% SDS, 10% glycerol, 5% mercap-
toethanol, 0.0025% bromophenol blue, H
 
2
 
O, 0.8) in a 1:5 dilution
(i.e. 80 
 
μ
 
L of sample to 20 
 
μ
 
L of SDS mixture) and heated at 90–
100 
 
°
 
C for 2 min. The solubilized, denatured proteins were then
separated through a SDS-PAGE gel and then nitrocellulose mem-
branes were placed in blocking buffer for 30 min (Tris-buffered
saline, pH 7.5, with 5% w/v skimmed milk powder). Following
washes in TTBS (Tris-buffered saline with 0.05% Tween-20), the
membrane was incubated with the primary antibodies (Erk1,2,
Anti-Active MAPK pAB, pTEpY, Rabbit, Promega, 1:5000) diluted
in TTBS containing 1% w/v skimmed milk powder to prevent
non-specific binding and left overnight. The membrane was washed
in TTBS and incubated for 1 h in goat anti-rabbit IgG conjugated
with horseradish peroxidase (Sigma), diluted at 1:1000. Western
blot analysis of the levels of total ERK and pERK1/2 were measured
for each experiment, and the levels of pERK1/2 were expressed as
a per cent of Total ERK in the same nerves (five nerves in each
experiment). Each treatment was replicated three to seven times,
and the mean (± SE) value of pERK1/2 as per cent of Total ERK was
calculated for each treatment group, and tested for significance
using Mann–Whitney tests.
 
Results
 
Calcium imaging and immuno-identification of 
NG2-glia 
 
in vitro
 
Optic nerves explants from P6 rats were seeded on
microgrid coverslips and maintained in culture for 15DIV.
During this period, NG2-glia and astrocytes migrate from
the explant (Fig. 1A). At DIV15 in serum-containing medium,
the vast majority of cells in the cultures were immunopositive
for NG2 (Fig. 1B) or GFAP (Fig. 1C). Double labelling for
NG2 and GFAP indicated that the majority of NG2-positive
cells were GFAP-negative (Fig. 1A). NG2-glia had small
somata and extended multiple thin processes that branched
three or more times along their length and bore small
varicosities along their length (Fig. 1B). Astrocytes were
either flat astrocytes (type-1) or process-bearing astrocytes
(type-2), which had large somata and numerous thick pro-
cesses that branched repeatedly (Fig. 1C). Both astrocytes and
NG2-glia loaded with Fura-2, but the two cell types could
Fig. 1 Glutamate evoked calcium signals in immuno-identified NG2-glia 
in vitro. Optic nerve explants were maintained in culture for 15 days and 
analysed by immunocytochemistry and calcium imaging. (A–C) Double 
immunofluorescence labelling for NG2 (green) and GFAP (red) showing 
astrocytes and NG2-glia (some indicated by asterisks) that have migrated 
from the optic nerve explant (A), and illustrating the distinct morphologies 
of NG2-glia (B) and astrocytes (C). (D–F) Cells cultured on microgrids 
were loaded with Fura-2 and identified as NG2-glia or astrocytes on the 
basis of their morphology (D). The response to ATP (D) and glutamate or 
kainate (E) was recorded, and at the end of the experiment, the cellular 
identify of NG2-glia was confirmed by immunocytochemistry (F). Fura-2 
ratiometric images of changes in the F340:F380 ratio illustrate that 
application of 100 μM ATP (D) or kainate (E) evokes raised [Ca2+]i in 
identified NG2-glia and neighbouring astrocytes. (G) Traces of the 
change in [Ca2+]i in individual NG2-glia show that ATP evoked a rapid and 
transient rise in [Ca2+]i, whereas glutamate and kainate evoked sustained 
rises in [Ca2+]i. Scale bar 25 μm in (A), 10 μm in (B–F).
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be distinguished readily by their distinctive morphologies
at the time of calcium imaging, and NG2-glial cell pheno-
type was confirmed at the end of the experiment by
immunolabelling. Thus, explant cultures were loaded with
Fura-2 and a field that contained cells morphologically
identified as NG2-glia was selected for calcium imaging
(Fig. 1D,E). The grid co-ordinates of cells were noted and
immunolabelling for NG2 was performed at the end of the
experiment (Fig. 1F) so that calcium recordings could be
related to positively identified NG2-glia (Fig. 1G). Fig. 1D–
G illustrates a typical experiment, in which cultures of
NG2-glia and neighbouring NG2-immunonegative astrocytes
respond to bath administration of ATP, the glutamate
receptor agonist kainate, and glutamate, all at 100 μM
(Fig. 1G). In NG2-glia (n = 19 cells from 6 experiments),
ATP evoked a rapid and large increase in [Ca2+]i, which
decayed during application of the agonist (Fig. 1G), whereas
glutamate and kainate evoked a sustained increase in
[Ca2+]i, which was generally slower to peak and to recover
to baseline (Fig. 1G).
Glutamate receptor activation evokes raised [Ca2+]i 
in NG2-glia in situ
Calcium imaging was performed on isolated intact rat
optic nerves aged P15-P20 in which NG2-glia were identified
by live cell immunolabelling (n = 5 nerves), and by post hoc
immunolabelling (n = 6 nerves) (Fig. 2). Cell somata of
NG2-positive (n = 17 cells) and NG2-negative cells (n = 196
cells) were selected as ROI (Fig. 2A), and the response to
100 μM ATP (Fig. 2C) and 100 μM glutamate (Fig. 2D) was
measured as the change in the F340:F380 ratio relative to
the baseline fluorescence (Fig. 2E) within a single plane of
focus. NG2-glia identified either by live cell immunolabelling
or by post hoc immunolabelling were observed to respond
to both ATP and glutamate, as did NG2-immunonegative
glia. The responses were similar to those recorded directly
in NG2-glia in vitro (see above): ATP evoked a rapid and
transient increase in [Ca2+]i that began to fall in the
presence of the agonist and recovered rapidly to baseline
on removal of the agonist, whereas glutamate evoked a
slower rise in [Ca2+]i that was sustained in the presence of
the agonist and recovered slowly to baseline after 50–60 s
(Fig. 2E). Comparison of NG2-glia and NG2-negative glia
indicated the amplitude of the response to glutamate
was significantly greater in NG2-glia (P < 0.05, unrelated
t-test), whereas there was no significant difference in the
response to ATP (P > 0.05, unrelated t-test). Although the
NG2-negative glial cells were not positively identified in
these experiments, the published evidence indicates that
the vast majority of these loaded cells will be astrocytes
(Fern, 1998). Furthermore, we have demonstrated that ATP
and glutamate evoke raised [Ca2+]i in astrocytes, using optic
nerves from mice in which astrocytes express green fluorescent
protein (Hamilton et al. 2008). Moreover, we have not
observed expression of NG2 by astrocytes in the optic nerve
(Butt et al. 1999, 2005), and so the response describe here
for NG2-positive and NG2-negative cells is respectively that
of NG2-glia and astrocytes. We took advantage of this fact,
and that comparison of NG2-positive and NG2-negative
glia indicate they respond similarly to glutamate, to examine
the effects of CTZ (10 μM) and NBQX (100 μM) on unidentified
glia, which would comprise astrocytes and NG2-glia (Fig. 3).
CTZ specifically acts on AMPA receptors to maintain them
Fig. 2 Glutamate evoked calcium signals in immuno-identified NG2-glia in situ. (A) NG2-glia were identified by live cell immunolabelling, and cell 
somata were selected as regions of interest (ROI); two NG2-positive cells are identified (encircled), in addition to neighbouring NG2-negative cells 
(asterisks), which are likely to be astrocytes. (B–D) Images of Fura-2 fluorescence, illustrating baseline levels (B), and the peak response to ATP (C) and 
glutamate (D), in the cells identified in A. (E) Traces of the change in [Ca2+]i in individual NG2-immunopositive (blue lines) and NG2-immunonegative 
(black lines). (F) Bar graph illustrating the mean peak responses (± SE) in NG2-immunopositive (n = 17 cells from six nerves) and NG2-immunonegative 
glia (n = 196 cells from six nerves). ***P < 0.001, unpaired t-test. Scale bars in A–D = 20 μm.
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in an open state, whereas NBQX is a specific antagonist
for AMPA receptors. In paired recordings from 148 cells in
three nerves, the response to glutamate was measured
first (Fig. 3A), then to glutamate in the presence of CTZ
(Fig. 3B), and then to glutamate plus CTZ in the presence
of NBQX (Fig. 3C). In all cells that responded to glutamate
(n = 148) we found that the response to glutamate was
markedly increased in CTZ by over 350%, and this was
significantly decreased by NBQX to 45 ± 4% of the gluta-
mate response in the same cells (Fig. 3D; Mann–Whitney test,
P < 0.001). These results provide evidence that AMPA-type
iGluR mediate raised [Ca2+]i in NG2-glia and astrocytes.
Glutamate receptor activation induces an injury 
response in NG2-glia in vivo
Over-activation of iGluR results in calcium-dependent
excitotoxicity in OPCs (Liu et al. 2002), and demyelinating
lesions in the optic nerve in vivo which persist for over
2 weeks (Matute et al. 1997; Matute, 1998). We therefore
examined the effects of iGluR activation on NG2-glia
in vivo 7 dpi following a subpial focal injection of kainate
(n = 3; Fig. 4), compared with injection of saline in controls
(n = 3). The injection site was identified by monastrol blue
and nerve sections were immunolabelled for NG2 and
GFAP, and quantitative analysis of immunofluorescence
intensity (FI) was performed (Fig. 5). In untreated nerves,
NG2-glia are uniformly distributed and have small cell
bodies, from which fine branching processes extend radially
(Fig. 4A), whereas GFAP-immunopositive astrocyte processes
are thicker and extend transversely and longitudinally
through the nerve (Fig. 4B). Following injection with saline,
there was some disruption of the cytoarchitecture of
NG2-glia and astrocytes at the injection site (Fig. 4C,D),
but no evidence of increased cellular density or immuno-
labelling (Fig. 5). In contrast, following injection of kainate,
there was marked disruption of the cytoarchitecture of
both NG2-glia and astrocytes (Fig. 4E–H). We did not observe
cross-reactivity between NG2 and GFAP immunolabelling,
but there was close apposition between the processes of
astrocytes and NG2-glia, and this is more evident at the
site of gliosis, where their processes intertwine to form
scar tissue. These may appear as colocalization, but the
immunolabelling was quite separate and we did not observe
co-expression of NG2 and GFAP. It was not possible to
count individual NG2-glia, because of the intensity of NG2
immunolabelling at the injection site, and so we quanti-
fied the relative changes in FI compared to normal tissue,
keeping all settings constant for each slide (Fig. 5A). The
monastral blue used to identify the injection site obscured
immunolabelling of both NG2 and GFAP at the injection
site, and FI here was zero. Analysis of the penumbra both
proximal and distal to the lesion site indicated a significant
increase in immunofluorescence, which was more pro-
nounced for NG2 than GFAP (Fig. 5B). In comparison, GFAP
immunolabelling was raised above control levels over a
wider area, 500 μm away from the injection site, whereas
the increase in NG2 immunolabelling was highly localized
to the injection site (Fig. 5B).
Glutamate receptor activation decreases axonal 
conduction
Axonal conduction properties were analysed by measur-
ing the CAP at 7 dpi following in vivo injection of saline,
kainate or TTX (Fig. 6). The CAP is an average of the action
potentials in all the axons of the nerve, related to axon
number and diameter. Injection of saline was used as a
negative control, and TTX was used as a positive control
because it blocks Na+ channels responsible for action
potential propagation and blocks myelination (Demerens
et al. 1996). Following saline injection, there was no sig-
nificant change in the CAP amplitude, whereas TTX caused
Fig. 3 Glutamate acts on AMPA receptors. The glutamate response was 
examined by Fura-2 ratiometry in unidentified glia. In paired 
experiments, the response to glutamate (A) was markedly increased in 
10 μM cyclothiazide (B), which specifically acts on AMPA receptors to 
maintain them in an open state, and was blocked by 100 μM NBQX (C), 
an AMPA receptor antagonist. (D) Bar graph of mean data (± SE; n = 148 
cells in three nerves) demonstrates the results were statistically 
significant. ***P < 0.001, Mann–Whitney test.
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a complete loss of the CAP (Fig. 6A). Administration of
kainate resulted in a significant decrease in the CAP
(Fig. 6A), with an amplitude 19 ± 14% compared to saline-
treated nerves (Fig. 6B).
Glutamate receptor activation results in glial ERK1/2 
phosphorylation
The results presented above show that glutamate evokes
raised [Ca2+]i in NG2-glia and astrocytes, and that injection
of the glutamate receptor agonist kainate into the optic
nerve evoked reactive gliosis in NG2-glia and astrocytes.
An important calcium-dependent intracellular signalling
pathway that is regulated by glutamate is phosphorylation
of ERK1/2, which are mitogen-activated kinases (MAPK)
that regulate multiple cellular processes, including cell
proliferation. We therefore examined whether there is
evidence that glutamate affects levels of phosphorylated
ERK1/2 (pERK1/2), using Western blot (Fig. 7). Nerves were
isolated intact and incubated in either aCSF (untreated
controls), ZERO-Calcium CSF, or aCSF containing NBQX
(to block AMPA receptors), or aCSF containing kainate (to
activate AMPA-kainate glutamate receptors); five nerves
were used each time to provide sufficient protein for
Western blot, and each treatment was replicated at least
three times. Representative blots of the levels of Total ERK
and pERK1/2 are illustrated in Fig. 7A, and the mean levels
of pERK1/2 expressed as a per cent of Total ERK in the
same nerves for each treatment group are illustrated in
Fig. 7B. The results demonstrated significant statistical
differences between the mean data for the experimental
groups (ANOVA followed by Mann–Whitney tests), although
Fig. 4 NG2 and GFAP immunolabelling in 
uninjected optic nerves (A,B) and at 7 dpi 
following in vivo injection of saline (C,D) or 
kainate (E–H). Typical distribution of NG2-glia 
(A) and GFAP-positive astrocyte processes (B) 
was observed in untreated nerves. NG2 
labelling was decreased following saline 
injection (C), whereas GFAP immunolabelling 
appeared increased (D). Injection of kainate 
resulted in increased expression of NG2 (E) and 
GFAP (F) at the injection site (asterisk). Higher 
magnification illustrates the increased density 
of NG2+ (G, arrows) and GFAP+ (H) cells and 
processes at the injection penumbra (black 
asterisk). Scale bar = 80 μm in (A,B,E) and 
40 μm in (C,D,G,H).
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a wide range of pERK1/2 levels were observed in control
(aCSF) and kainate-treated groups. The results indicated
that levels of pERK1/2 were high in isolated nerves
incubated in normal aCSF (22 ± 4% of total ERK, n = 7),
and significantly decreased by removal of extracellular
Ca2+ (4 ± 0.4% of total ERK, n = 3; P < 0.001, Mann–Whit-
ney test), or in CSF containing NBQX (7 ± 2% of Total ERK,
n = 3; P < 0.01, Mann–Whitney test); there was no signifi-
cant difference between nerves incubated in Ca2+-free CSF
or in CSF containing NBQX (Fig. 7B). There was no signifi-
cant difference between nerves incubated in normal aCSF
and in CSF containing kainate (17 + 4% of Total ERK, n = 7).
The results indicate that endogeneous glutamate is released
in the isolated nerves to act on NBQX-sensitive AMPA
receptors and mediate calcium-dependent ERK1/2 phos-
phorylation, and so activation of AMPA-kainate receptors
with kainate had no additional effect.
Discussion
We have examined the response of NG2-glia and astrocytes
to glutamate receptor activation in the rat optic nerve.
Glutamate is shown to evoke raised intracellular [Ca2+] in
optic nerve NG2-glia identified by immunolabelling in
vitro and in situ. Equivalent results have been show for
astrocytes previously (Hamilton et al. 2008). In addition,
we show that injection of kainate into the optic nerve to
activate AMPA-kainate glutamate receptors results in reac-
tive gliosis in NG2-glia and astrocytes, and in reduced
axonal conduction. Finally, we show that levels of pERK1/
2 in the isolated nerve are reduced by removal of extra-
cellular calcium and blockade of AMPA receptors with NBQX,
indicating that the release of endogenous glutamate acti-
vates calcium-dependent MAPK pathways. These results
provide a possible mechanism by which glutamate-mediated
calcium entry could regulate an injury response of NG2-glia
in white matter pathology.
Glutamate and ATP evoked an increase in [Ca2+]i in optic
nerve NG2-glia, which is equivalent to that described
previously in rat optic nerve glia in situ (Kreigler & Chiu,
1993; James & Butt, 2002; Butt et al. 2004; Hamilton et al.
2008). There have been no previous studies on the calcium
responses of NG2-glia, but NG2-glia have an OPC antigenic
phenotype in vivo and in vitro (Nishiyama et al. 1996a,b),
and it is possible to compare our findings with previous
studies on OPCs. The ATP response we observed in NG2-
glia is consistent with studies showing ATP-evoked raises
[Ca2+]i in perinatal OPCs in vitro (Kastritsis & McCarthy,
1993; Kirischik et al. 1995; Agresti et al. 2005), and a study
showing the presence of several ionotropic P2X (1,2,3,4,7)
and metabotropic P2Y (1,2,4) receptor subtypes on OPCs
(Agresti et al. 2005). Our finding that glutamate evokes
calcium signals in NG2-glia corroborates patch-clamp studies
Fig. 5 Quantification of immunofluorescence intensity for NG2 and 
GFAP. (A) Illustration of the sites of fluorescence intensity measurements 
in the injected optic nerve. D1 and D2 are the proximal and distal sites up 
to 500 μm away from the lesion site, L; P1 and P2 measurement sites were 
in the penumbra. The percentage change in fluorescence of NG2 and 
GFAP was calculated in randomly selected sections (n = 3). (B) An 
increase in NG2 and GFAP expression was seen in the penumbra 
following injection of kainate. A lack of fluorescence is seen at (A) due 
to the monastrol blue. Data are expressed as a percentage of normal 
fluorescence intensity and plotted as mean ± SE.
Fig. 6 Compound action potentials (CAPs) 7 days after in vivo injection of saline, kainate (1 mg mL−1) or TTX (100 μM). (A) Traces illustrate the typical 
CAPs measured in each experimental group. (B) Bar graph of mean (± SE) change in peak CAP amplitude (n = 3–6). ***P < 0.001, Mann–Whitney test.
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showing that NG2-glia express AMPA-type glutamate
receptors in situ in the hippocampus, cerebellum, corpus
callosum and optic nerve (Bergles et al. 2000; Lin & Bergles,
2004; Lin et al. 2005; Kukley et al. 2007; Ziskin et al. 2007).
In addition, a number of studies have shown that AMPA
receptors mediate calcium signals in OPCs (Borges et al.
1994; Pende et al. 1994; Holtzclaw et al. 1995). Glutamate-
mediated calcium signals in NG2-glia are consistent with
calcium entering through calcium-permeable AMPA
receptors, as indicated in patch-clamp studies (Ziskin et al.
2007). However, activation of AMPA receptors may also
cause depolarization due to sodium influx, and calcium
entry through voltage-operated calcium channels (VOCC),
which are expressed by OPCs (Blankenfeld et al. 1992). It is
not known whether NG2-glia express VOCC in vivo, and
further studies on calcium signalling in NG2-glia are required
to help resolve this issue.
Our results on the effects of kainate injected into the
optic nerve indicate that activation of glutamate receptors
can mediate an injury response in NG2-glia, as well as
astrocytes. Following injection of kainate into the optic
nerve, there was an increase in the density of NG2-glia,
similar to that described following intracerebral injection
of kainate (Ong & Levine, 1999). A ‘reactive gliosis’ is also
seen in NG2-glia and astrocytes following axon degeneration
in the optic nerve (Butt et al. 2002, 2004; Greenwood &
Butt, 2003). However, axon degeneration resulted in an
extensive gliosis along the entire tract (Greenwood & Butt,
2003), whereas the response of NG2-glia and astrocytes to
kainate was localized to the injection site, consistent
with previous studies showing that kainate does not result
in axonal damage and degeneration (Matute et al. 1997;
Matute, 1998). Notably, the optic nerve does not contain
neuronal somata and so injected kainate acts directly on
glial cells, not indirectly via its excitotoxic effect on neurons.
It is important to recognize that oligodendrocytes also
express AMPA-kainate receptors and injection of kainate
in the optic nerve results in demyelination (Matute et al.
1997; Matute, 1998). NG2-glia would be expected to respond
to this demyelination by proliferation and migration into
the lesion site (Chari & Blakemore, 2002; Watanabe et al.
2002, 2004; Polito & Reynolds, 2005). Nonetheless, NG2-glia
express functional AMPA receptors and we show kainate
evokes raised calcium in NG2-glia, so it is reasonable to
conclude that kainate injected into the nerve could have
acted directly on NG2-glia to induce the observed injury
response. The electrophysiological recordings show decreased
axonal conduction across the lesion, which correlated with
glial scar formation and with the demyelination that has
been reported previously (Matute et al. 1997; Matute, 1998).
Notably, kainate did not induce the loss of NG2-glia in vivo.
This is in comparison with findings on OPCs in vitro, where
calcium-permeable AMPA-kainate receptors mediate
toxicity in OPCs (Kavanaugh et al. 2000; Itoh et al. 2002;
Liu et al. 2002; Deng et al. 2003). This may be further
evidence that NG2-glia in vivo do not behave the same as
OPCs in vitro (Greenwood & Butt, 2002).
Analysis of ERK1/2 phosphorylation indicated a role for
glutamate-mediated activation of MAPK signalling path-
ways in the optic nerve. Phosphorylated ERK1/2 was detected
in nerves incubated in normal aCSF, and this was blocked
by NBQX and by removal of extracellular Ca2+. This indicates
that ERK1/2 phosphorylation was induced by endogenous
glutamate, presumably released from axons and astrocytes
(Kukley et al. 2007; Ziskin et al. 2007; Hamilton et al. 2008).
It is possible that glutamate is released in response to the
surgical procedure of nerve isolation, and that the phos-
phorylation of ERK1/2 represents an early event in the
pathological response of glial cells. Notably, kainate had
no significant effect on pERK1/2 levels compared with
untreated nerves, suggesting that further activation of
AMPA-kainate receptors had no additional effect over
endogenous glutamate. The Western blot analysis of
homogenates of intact tissue did not identify the cells
responding to glutamate, and these are likely to include
astrocytes, oligodendrocytes and NG2-glia. However,
several lines of evidence are consistent with this pathway
regulating NG2-glia: (1) glutamate triggers raised calcium
Fig. 7 Glutamate increases ERK1/2 phosphorylation. Levels of pERK1/2 
were measured using Western blot and compared with total ERK1/2, 
following incubation of nerves in aCSF (untreated controls), 
ZERO-Calcium aCSF, aCSF containing 10 μM NBQX, or aCSF containing 
100 μM kainate. (A) Representative Western blots of pERK1/2 and Total 
ERK for each treatment. (B) Mean (+ SE, n = 4–7) levels of pERK1/2 
expressed as a per cent of total ERK in each treatment group. Removal 
of extracellular calcium or addition of the AMPA-receptor agonist 
significantly reduced levels of pERK1/2, compared with controls. Kainate 
had no significant effect compared with controls. *P < 0.05, **P < 0.01, 
***P < 0.001, Mann–Whitney test.
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in NG2-glia (this study); (2) glutamate regulates OPC
proliferation (Yuan et al. 1998); (3) MAPK regulate OPC
proliferation (Soliven, 2001); (4) glutamate receptor activa-
tion produces calcium-dependent MAPK phosphorylation
(Pende et al. 1997; Liu et al. 1999). These results provide a
possible intracellular link between glutamate-mediated
calcium influx and glutamate-receptor-mediated reactive
gliosis in NG2-glia.
In conclusion, we provide evidence that glutamate and ATP
evoke calcium signals in NG2-glia, which may be important
in regulating the pathological functions of NG2-glia (Matute
et al. 2007). It is generally undisputed that NG2-glia have
an OPC antigenic phenotype (Nishiyama et al. 2005), and
glutamate is known to inhibit OPC differentiation (Gallo
et al. 1996; Yuan et al. 1998). Hence, glutamate released by
axons (Kukley et al. 2007; Ziskin et al. 2007) may serve to
maintain NG2-glia in a quiescent form under physiological
conditions. However, over-activation of glutamate receptors
mediates an injury response in white matter NG2-glia
similar to that observed in grey matter (Ong & Levine,
1999). One of the most prominent features of NG2-glial cell
biology is their response to most forms of CNS insults
(Levine, 1994; Ong & Levine, 1999; Tan et al. 2005, 2006),
and the results support a role for glutamate in this injury
response (Butt et al. 2002). Moreover, NG2-glia are a
source of remyelinating oligodendrocytes following
demyelination, and the gliotic response of NG2-glia to
glutamate may be important in promoting the regenera-
tion oligodendrocytes by NG2-glia.
Acknowledgements
Niki Hamilton was in receipt of a PhD studentship from the
Anatomical Society of Great Britain and Ireland. Supported by the
BBSRC. We thank Dr Rob Williams for advice with the ERK1/2
Western blot experiments.
References
Agresti C, Meomartini ME, Amadio S, et al. (2005) Metabotropic
P2 receptor activation regulates oligodendrocyte progenitor
migration and development. Glia 50, 132–144.
Aguirre A, Chittajallu R, Belachew S, Gallo V (2004) NG2-expressing
cells in the subventricular zone are type C-like cells that contribute
to interneuron generation in the postnatal hippocampus. J Cell
Biol 165, 575–589.
Alberdi E, Sanchez-Gomez MV, Matute C (2005) Calcium and glial
cell death. Cell Calcium 38, 417–425.
Belachew S, Chittajallu R, Aguirre AA, et al. (2003) Postnatal
NG2 proteoglycan-expressing progenitor cells are intrinsically
multipotent and generate functional neurons. J Cell Biol 161,
169–186.
Bergles DE, Roberts JDB, Somogyi P, Jahr CE (2000) Glutamatergic
synapses on oligodendrocyte precursor cells in the hippocampus.
Nature 405, 187–191.
Blankenfeld G, Verhkratsky A, Kettenmann H (1992) Ca2+ channel
expression in the oligodendroglial lineage. Eur J Neurosci 4,
1035–1048.
Bolton S, Butt AM (2005) The optic nerve: a model for axon-glial
interactions. J Pharmacol Toxicol Methods 51, 221–233.
Borges K, Ohlemeyer C, Trotter J, Kettenmann H (1994) AMPA/
kainate receptor activation in murine oligodendrocyte precursor
cells leads to activation of a cation conductance, calcium influx
and blockade of delayed rectifying K+ channels. Neuroscience
63, 135–149.
Butt AM (2006) Neurotransmitter-mediated calcium signalling in
oligodendrocyte physiology and pathology. Glia 54, 666–675.
Butt AM, Duncan A, Hornby MF, et al. (1999) Cells expressing the
NG2 antigen contact nodes of Ranvier in adult CNS white matter.
Glia 26, 84–91.
Butt AM, Kiff J, Hubbard P, Berry M (2002) Synantocytes: new func-
tions for novel NG2 expressing glia. J Neurocytol 31, 551–565.
Butt AM, Pugh M, Hubbard P, James G (2004) Functions of optic
nerve glia: axoglial signalling in physiology and pathology. Eye
18, 1110–1121.
Butt AM, Hamilton N, Hubbard P, Pugh M, Ibrahim M (2005)
Synantocytes: the fifth element. J Anat 207, 695–706.
Chari DM, Blakemore WF (2002) Efficient recolonisation of progenitor-
depleted areas of the CNS by adult oligodendrocyte progenitor
cells. Glia 37, 307–313.
Demerens C, Stankoff B, Logak M, et al. (1996) Induction of mye-
lination in the central nervous system by electrical activity.
Proc Natl Acad Sci U S A 93, 9887–9892.
Deng W, Rosenberg PA, Volpe JJ, Jensen FE (2003) Calcium-
permeable AMPA/kainate receptors mediate toxicity and pre-
conditioning by oxygen-glucose deprivation in oligodendrocyte
precursors. Proc Natl Acad Sci U S A 100, 6801–6806.
Fern R (1998) Intracellular calcium and cell death during ischemia
in neonatal rat white matter astrocytes in situ. J Neurosci 18,
7232–7243.
Ffrench-Constant C, Raff MC (1986) Proliferating bipotential glial
progenitor cells in adult rat optic nerve. Nature 319, 499–502.
Fulton BP, Burne JF, Raff MC (1992) Visualization of O-2A progen-
itor cells in developing and adult rat optic nerve by quisqualate-
stimulated cobalt uptake. J Neurosci 12, 4816–4833.
Greenwood K, Butt AM (2003) Evidence that perinatal and adult
NG2-glia are not conventional oligodendrocyte progenitors and
do not depend on axons for their survival. Mol Cell Neurosci 23,
544–558.
Hamilton N, Vayro S, Kirchhoff F, et al. (2008) Mechanisms of
ATP- and glutamate-mediated calcium signaling in white matter
astrocytes. Glia 56, 734–749.
Holtzclaw LA, Gallo V, Russell JT (1995) AMPA receptors shape Ca2+
responses in cortical oligodendrocyte progenitors and CG-4 cells.
J Neurosci Res 42, 124–130.
Itoh T, Beesley J, Itoh A, et al. (2002) AMPA glutamate receptor-
mediated calcium signaling is transiently enhanced during
development of oligodendrocytes. J Neurochem 81, 390–402.
James G, Butt AM (2002) P2Y and P2X purinoceptor mediated Ca2+
signalling in glial cell pathology in the central nervous system.
Eur J Pharmacol 447, 247–260.
Kastritsis CH, McCarthy KD (1993) Oligodendroglial lineage cells
express neuroligand receptors. Glia 8, 106–113.
Kavanaugh B, Beesley J, Itoh T, Itoh A, Grinspan J, Pleasure D (2000)
Neurotrophin-3 (NT-3) diminishes susceptibility of the oligo-
dendroglial lineage to AMPA glutamate receptor-mediated excito-
toxicity. J Neurosci Res 60, 725–732.
Kirischuk S, Scherer J, Kettenmann H, Verkhratsky A (1995)
Activation of P2-purinoreceptors triggered Ca2+ release from
InsP3-sensitive internal stores in mammalian oligodendrocytes.
J Physiol 483, 41–57.
Glutamate receptor activation in NG2-glia, N. Hamilton et al.
© 2009 The Authors
Journal compilation © 2009 Anatomical Society of Great Britain and Ireland
218
Kondo T, Raff M (2000) Oligodendrocyte precursor cells repro-
grammed to become multipotential CNS stem cells. Science 289,
1754–1757.
Kriegler S, Chiu SY (1993) Calcium signaling of glial cells along
mammalian axons. J Neurosci 13, 4229–4245.
Kukley M, Capetillo-Zarate E, Dietrich D (2007) Vesicular gluta-
mate release from axons in white matter. Nat Neurosci 10, 311–
320.
Levine JM (1994) Increased expression of the NG2 chondroitin-
sulfate proteoglycan after brain injury. J Neurosci 14, 4716–
4730.
Levine JM, Card JP (1987) Light and electron microscopic localiza-
tion of a cell surface antigen (NG2) in the rat cerebellum: asso-
ciation with smooth protoplasmic astrocytes. J Neurosci 7, 2711–
2720.
Levine JM, Stallcup WB (1987) Plasticity of developing cerebellar
cells in vitro studied with antibodies against the NG2 antigen.
J Neurosci 7, 2721–2731.
Lin S-C, Bergles DE (2004) Synaptic signaling between GABAergic
interneurons and oligodendrocyte precursor cells in the hippo-
campus. Nat Neurosci 7, 24–32.
Lin S-C, Huck JHJ, Roberts JD, Macklin WB, Somogyi P, Bergles DE
(2005) Climbing fiber innervation of NG2-expressing glia in the
mammalian cerebellum. Neuron 46, 773–785.
Liu HN, Larocca JN, Almazan G (1999) Molecular pathways medi-
ating activation by kainate of mitogen-activated protein kinase
in oligodendrocyte progenitors. Brain Res Mol Brain Res 66, 50–
61.
Liu HN, Giasson BI, Mushynski WE, Almazan G (2002) AMPA
receptor-mediated toxicity in oligodendrocyte progenitors
involves free radical generation and activation of JNK, calpain
and caspase 3. J Neurochem 82, 398–409.
Matute C (1998) Characteristics of acute and chronic kainate exci-
totoxic damage to the optic nerve. Proc Natl Acad Sci U S A 95,
10229–10234.
Matute C, Sanchez-Gomez MV, Martinez-Millan L, Miledi R (1997)
Glutamate receptor mediated toxicity in optic nerve oligodendro-
cytes. Proc Natl Acad Sci USA 94, 8830–8835.
Matute C, Domercq M, Sanchez-Gomez M-V (2006) Glutamate-
mediated glial injury: mechanisms and clinical importance. Glia
53, 212–224.
Matute C, Alberdi E, Domercq M, et al. (2007) Excitotoxic damage
to white matter. J Anat 210, 693–702.
Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB (1996a)
Co-localization of NG2 proteoglycan and PDGF alpha-receptor
on O2A progenitor cells in the developing rat brain. J Neurosci
Res 43, 299–314.
Nishiyama A, Lin XH, Giese N, Heldin CH, Stallcup WB (1996b)
Interaction between NG2 proteoglycan and PDGF alpha-receptor
on O2A progenitor cells is required for optimal response to PDGF.
J Neurosci Res 43, 315–330.
Nishiyama A, Yang Z, Butt A (2005) Astrocytes and NG2-glia: what’s
in a name? J Anat 207, 687–693.
Ong WY, Levine JM (1999) A light and electron microscopic study
of NG2 chondroitin sulfate proteoglycan-positive oligodendrocyte
precursor cells in the normal and kainate-lesioned rat hippoc-
ampus. Neuroscience 92, 83–95.
Pende M, Holtzclaw LA, Curtis JL, Russell JT, Gallo V (1994)
Glutamate regulates intracellular calcium and gene expression
in oligodendrocyte progenitors through the activation of DL-
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid recep-
tors. Proc Natl Acad Sci U S A 91, 3215–3219.
Pende M, Fisher TL, Simpson PB, Russell JT, Blenis J, Gallo V (1997)
Neurotransmitter- and growth factor-induced cAMP response
element binding protein phosphorylation in glial cell progenitors:
role of calcium ions, protein kinase C, and mitogen-activated
protein kinase/ribosomal S6 kinase pathway. J Neurosci 17, 1291–
1301.
Polito A, Reynolds R (2005) NG2-expressing cells as oligodendrocyte
progenitors in the normal and demyelinated adult central nervous
system. J Anat 207, 707–716.
Raff MC, Miller RH, Noble M (1983) A glial progenitor cell that
develops in vitro into an astrocyte or an oligodendrocyte depend-
ing on culture medium. Nature 303, 390–396.
Sandvig A, Berry M, Barrett LB, Butt A, Logan A (2004) Myelin-,
reactive glia-, and scar-derived CNS axon growth inhibitors:
expression, receptor signaling, and correlation with axon regen-
eration. Glia 46, 225–251.
Soliven B (2001) Calcium signalling in cells of oligodendroglial
lineage. Microsc Res Tech 52, 672–679.
Stallcup WB, Beasley L (1987) Bipotential glial precursor cells of
the optic nerve express the NG2 proteoglycan. J Neurosci 7,
2737–2744.
Tan AM, Zhang W, Levine JM (2005) NG2: a component of the glial
scar that inhibits axon growth. J Anat 207, 717–725.
Tan AM, Colletti M, Rorai AT, Skene JH, Levine JM (2006) Anti-
bodies against the NG2 proteoglycan promote the regeneration
of sensory axons within the dorsal columns of the spinal cord.
J Neurosci 26, 4729–4739.
Watanabe M, Toyama Y, Nishiyama A (2002) Differentiation of
proliferated NG2-positive glial progenitor cells in a remyelinating
lesion. J Neurosci Res 69, 826–836.
Watanabe M, Hadzic T, Nishiyama A (2004) Transient upregulation
of Nkx2.2 expression in oligodendrocyte lineage cells during
remyelination. Glia 46, 311–322.
Wigley R, Hamilton N, Nishiyama A, Kirchhoff F, Butt AM (2007)
Morphological and physiological interactions of NG2-glia with
astrocytes and neurons. J Anat 210, 661–670.
Yuan X, Eisen AM, McBain CJ, Gallo V (1998) A role for glutamate
and its receptors in the regulation of oligodendrocyte develop-
ment in cerebellar tissue slices. Development 125, 2901–
2914.
Zhu X, Bergles DE, Nishiyama A (2008) NG2 cells generate both
oligodendrocytes and gray matter astrocytes. Development
135, 145–157.
Ziskin JL, Nishiyama A, Rubio M, Fukaya M, Bergles DE (2007)
Vesicular release of glutamate from unmyelinated axons in white
matter. Nat Neurosci 10, 321–330.
